INS and psoriasis: It seems to be no deleterious influence of the drug on lipid profile ofpatients with psoriasis according to the studies, although none of these hasbeen specifically designed for the observation of this event, but rather todetermine increase of BMI and insulin tolerance in psoriaticpatients.33,34,44